April 2026
The global cardiac rhythm management devices market size was calculated at USD 23.87 billion in 2025 and is predicted to increase from USD 25.36 billion in 2026 to approximately USD 43.19 billion by 2035, expanding at a CAGR of 6.11%.
March 2026
The global cardiac AI monitoring and diagnostics market size was evaluated at USD 4.48 billion in 2025 and is predicted to hit around USD 18.89 billion by 2035, growing at a CAGR of 15.48%.
March 2026
The global cardiac valvulotome market size was estimated at USD 121.34 million in 2025 and is expected to hit around USD 192.69 billion by 2035, growing at a CAGR of 4.73%.
February 2026
The cardiac arrhythmia monitoring devices market size was valued at USD 8.40 billion in 2025 and is predicted to surge around USD 15.89 billion by 2035, at a CAGR of 6.58%.
January 2026
The global cardiac monitoring and cardiac rhythm management devices market size was evaluated at USD 32.35 billion in 2025 and is predicted to hit around USD 68.82 billion by 2035, growing at a CAGR of 7.84%.
January 2026
The global cardiac pacemaker market size is valued at USD 5.87 billion in 2025 and is predicted to increase from USD 6.14 billion in 2026 to approximately USD 10.10 billion by 2035, expanding at a CAGR of 5.58% from 2026 to 2035.
December 2025
The global cardiac monitoring market size is calculated at USD 10.06 billion in 2025 and is predicted to increase from USD 10.87 billion in 2026 to approximately USD 21.72 billion by 2035, expanding at a CAGR of 8.00% from 2026 to 2035.
December 2025
The global cardiac troponin market size is calculated at USD 4.30 billion in 2025 and is predicted to increase from USD 4.75 billion in 2026 to approximately USD 11.44 billion by 2035, expanding at a CAGR of 10.28% from 2026 to 2035.
December 2025
The global cardiac mapping market size is calculated at USD 2.62 billion in 2025 and is predicted to increase from USD 2.90 billion in 2026 to approximately USD 7.09 billion by 2035, expanding at a CAGR of 10.47% from 2026 to 2035.
December 2025
The global cardiac resynchronization therapy market size is calculated at USD 9.05 billion in 2025 and is predicted to increase from USD 9.73 billion in 2026 to approximately USD 18.33 billion by 2035, expanding at a CAGR of 7.31% from 2026 to 2035.
October 2025
The global ambulatory cardiac monitoring devices market size was estimated at USD 8.51 billion in 2025 and is predicted to increase from USD 9.47 billion in 2026 to approximately USD 22.31 billion by 2034, expanding at a CAGR of 11.30% from 2025 to 2034.
August 2025
The global wearable cardiac devices market size surpassed USD 3.75 billion in 2024 and is estimated to hit around USD 32.16 billion by 2034 with a CAGR of 23.97%.
August 2025
The global cardiac biomarkers market size reached USD 21.20 billion in 2024 and is projected to surpass around USD 82.99 billion by 2034, with a remarkable CAGR of 14.62%.
July 2025
The global remote cardiac monitoring market size reached USD 3.80 billion in 2024 and is estimated to hit around USD 10.66 billion by 2034 with a CAGR of 10.87%.
June 2025
The global cardiac ablation market size was calculated at USD 5.11 billion in 2024 and is predicted to increase from USD 5.79 billion in 2025 to approximately USD 19.09 billion by 2034, expanding at a CAGR of 14.20% from 2025 to 2034.
April 2026
The global chemical API CDMO market size was evaluated at USD 16.80 billion in 2025 and is predicted to hit around USD 40.88 billion by 2035, growing at a CAGR of 9.30%.
April 2026
The global chemical drug CDMO market size was evaluated at USD 13.20 billion in 2025 and is predicted to hit around USD 29.84 billion by 2035, growing at a CAGR of 8.50%.
April 2026
The global sterility indicators market size is calculated at USD 1.39 billion in 2025 and is predicted to increase from USD 1.57 billion in 2026 to approximately USD 4.43 billion by 2035, expanding at a CAGR of 12.29% from 2026 to 2035.
April 2026
The cellular health screening market size was valued at USD 3.73 billion in 2025 and is expected to hit around USD 7.98 billion by 2035 at a CAGR of 7.90%.
April 2026
The global medical spa market size was estimated at USD 25.28 billion in 2025 and is projected to hit around USD 97.91 billion by 2035, with a remarkable CAGR of 14.50%.
April 2026
The global inflammatory bowel disease treatment market size is projected to hit around USD 32.46 billion by 2035 from USD 22.38 billion in 2025, with a CAGR of 3.79%.
April 2026
The global clinical chemistry analyzers market size is calculated at USD 17.18 billion in 2025 and is predicted to increase from USD 18.12 billion in 2026 to approximately USD 29.21 billion by 2035, expanding at a CAGR of 5.45% from 2026 to 2035.
April 2026
The global home infusion therapy market size was estimated at USD 41.83 billion in 2025 and is anticipated to reach around USD 90.65 billion by 2035, expanding at a CAGR of 8.04% from 2026 to 2035.
April 2026
The global smart insulin pens market size was calculated at USD 183.25 million in 2025, and is expected to reach around USD 756.34 million by 2035. The market is expanding at a solid CAGR of 15.23% over the forecast period 2026 to 2035.
April 2026
The global hemostats market size was evaluated at USD 3.11 billion in 2025 and is projected to hit around USD 5.96 billion by 2035 with a notable CAGR of 6.72%.
April 2026
The global opioids market size was accounted for USD 23.42 billion in 2025, and is predicted to increase from USD 23.77 billion in 2026 to approximately USD 27.17 billion by 2035 expanding at a CAGR of 1.5% from 2026 to 2035.
April 2026
The global theranostics market size is estimated to hit around USD 31.38 billion by 2035 increasing from USD 10.29 billion in 2025, with a CAGR of 11.8%.
April 2026
The global transdermal drug delivery systems market size was evaluated at USD 78.20 billion in 2025 and is predicted to hit around USD 239.43 billion by 2035, growing at a CAGR of 11.84%.
April 2026
The global pulmonary embolism market size is estimated to hit around USD 2.70 billion by 2035 increasing from USD 6.04 billion in 2025, with a CAGR of 8.38%.
April 2026
The global nasal drug delivery technology market size is calculated at USD 88.85 billion in 2025 and is predicted to increase from USD 95.49 billion in 2026 to approximately USD 179.41 billion by 2035, expanding at a CAGR of 7.28% from 2026 to 2035.